Company Sector
Cardio-Metabolic
Cardio-Metabolic includes companies targeting cardiovascular disease, obesity, diabetes, lipid disorders, and related metabolic conditions. This page highlights businesses exposed to some of the largest and most competitive treatment categories in biotech and pharma.
Why watch Cardio-Metabolic
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Cardio-Metabolic news
The latest feed items from companies currently grouped under Cardio-Metabolic.
- 01
NAMSNewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: NewAmsterdam Pharma
- 02
ALGSAligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
Source: Aligos Therapeutics
- 03
MLYSMineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Source: Mineralys Therapeutics
- 04
- 05
ALGSAligos Therapeutics Presents Positive Data at The Liver Meeting® 2026
Source: Aligos Therapeutics
- 06
- 07
- 08
MLYSMineralys Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Source: Mineralys Therapeutics
- 09
- 10
NAMSNewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
Source: NewAmsterdam Pharma
- 11
MISTMilestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Milestone Pharmaceuticals Inc.
- 12
VKTXViking Therapeutics to Participate at Upcoming Investor Conferences
Source: Viking Therapeutics
- 13
MLYSMineralys Therapeutics to Participate in Upcoming Investor Conferences
Source: Mineralys Therapeutics
- 14
NAMSNewAmsterdam Pharma to Participate at Upcoming Investor Conferences in November
Source: NewAmsterdam Pharma
- 15
MISTMilestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
Source: Milestone Pharmaceuticals Inc.
- 16
RYTMRhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update
Source: Rhythm Pharmaceuticals
- 17
RYTMRhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement
Source: Rhythm Pharmaceuticals
- 18
- 19
- 20
Companies in Cardio-Metabolic
35 companies tagged with Cardio-Metabolic.
Frequently Asked Questions
What does the Cardio-Metabolic sector include?
Cardio-Metabolic includes companies targeting cardiovascular disease, obesity, diabetes, lipid disorders, and related metabolic conditions. This page highlights businesses exposed to some of the largest and most competitive treatment categories in biotech and pharma.
How many companies are currently tagged with Cardio-Metabolic?
35 companies are currently grouped under Cardio-Metabolic on BioPharmSignal.
Which companies are most visible in the Cardio-Metabolic group right now?
ETNB, ALGS, ALT, BAYRY are among the companies currently shown on this sector page.
How can I watch news for Cardio-Metabolic?
Use the Watch button on this page to subscribe to Cardio-Metabolic headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Cardio-Metabolic?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Cardio-Metabolic.